{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:32:52Z","timestamp":1755221572991,"version":"3.43.0"},"reference-count":27,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2025.j007","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:12:13Z","timestamp":1738170733000},"page":"327-334","source":"Crossref","is-referenced-by-count":0,"title":["Neuromyelitis Optica Spectrum Disorder with Interstitial Pneumonia and Marked HyperCKemia as an Initial Presentation: A Case Report and Literature Review"],"prefix":"10.1620","volume":"266","author":[{"given":"Tomohiro","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Rheumatology, Kurashiki Central Hospital"},{"name":"Graduate School of Health Management, Keio University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Rheumatology, Kurashiki Central Hospital"},{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Rheumatology, Kurashiki Central Hospital"},{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Murabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Rheumatology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Asato, Y., Kamitani, T., Ootsuka, K., Kuramochi, M., Nakanishi, K., Shimada, T., Takahashi, T., Misu, T., Aoki, M., Fujihara, K. &amp; Kawabata, Y.(2018)  Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder.  <i>Intern. Med<\/i>., 57, 2981-2986.","DOI":"10.2169\/internalmedicine.0580-17"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Chen, H.X., Zhang, Q., Lian, Z.Y., Liu, J., Shi, Z.Y., Miao, X.H., Feng, H.R., Du, Q., Xie, J.L., Yao, S.L. &amp; Zhou, H.Y.(2017)  Muscle damage in patients with neuromyelitis optica spectrum disorder.  <i>Neurol. Neuroimmunol. Neuroinflamm<\/i>., 4, e400.","DOI":"10.1212\/NXI.0000000000000400"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cosgrove, J., Alli, S., Ramadan, H. &amp; Ford, H.L.(2014)  Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.  <i>Mult. Scler<\/i>., 20, 120-122.","DOI":"10.1177\/1352458513495939"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Deguchi, S., Deguchi, K., Sato, K., Yunoki, T., Omote, Y., Morimoto, N., Kurata, T., Ikeda, M., Takahashi, T., Aoki, M. &amp; Abe, K.(2012)  HyperCKemia related to the initial and recurrent attacks of neuromyelitis optica.  <i>Intern. Med<\/i>., 51, 2617-2620.","DOI":"10.2169\/internalmedicine.51.7898"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Delman, D., Peng, X., Zedek, D.C., Jewells, V., Chahin, N. &amp; Markovic-Plese, S.(2015)  Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder.  <i>J. Neuroimmunol<\/i>., 278, 108-111.","DOI":"10.1016\/j.jneuroim.2014.07.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Di Filippo, M., Franciotta, D., Massa, R., Di Gregorio, M., Zardini, E., Gastaldi, M., Terracciano, C., Rastelli, E., Gaetani, L., Iannone, A., Menduno, P., Floridi, P., Sarchielli, P. &amp; Calabresi, P.(2012)  Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.  <i>Neurology<\/i>, 79, 1182-1184.","DOI":"10.1212\/WNL.0b013e3182698d39"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Furube, A., Kadota, T., Gochi, M., Saito, S., Shibata, S., Inaki, S., Tone, K., Takagi, M., Matsuno, H., Araya, J., Yaguchi, H. &amp; Kuwano, K.(2022)  Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.  <i>Respir. Investig<\/i>., 60, 684-693.","DOI":"10.1016\/j.resinv.2022.06.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Guo, Y., Lennon, V.A., Popescu, B.F., Grouse, C.K., Topel, J., Milone, M., Lassmann, H., Parisi, J.E., Pittock, S.J., Stefoski, D., Balabanov, R. &amp; Lucchinetti, C.F.(2014)  Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum.  <i>JAMA Neurol<\/i>., 71, 1025-1029.","DOI":"10.1001\/jamaneurol.2014.775"},{"key":"9","doi-asserted-by":"crossref","unstructured":"He, D., Zhang, A., Li, Y., Cai, G., Li, Y. &amp; Guo, S.(2017)  Autoimmune aquaporin-4 induced damage beyond the central nervous system.  <i>Mult. Scler. Relat. Disord<\/i>., 18, 41-46.","DOI":"10.1016\/j.msard.2017.09.013"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Langille, M.M. &amp; Desai, J.(2015) Multisystem involvement in neuromyelitis optica. <i>Ann. Indian Acad. Neurol.<\/i>, 18, S56-S58.","DOI":"10.4103\/0972-2327.164830"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Malik, R., Lewis, A., Cree, B.A., Ratelade, J., Rossi, A., Verkman, A.S., Bollen, A.W. &amp; Ralph, J.W.(2014)  Transient hyperckemia in the setting of neuromyelitis optica (NMO).  <i>Muscle Nerve<\/i>, 50, 859-862.","DOI":"10.1002\/mus.24298"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H. &amp; Itoyama, Y.(2007)  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.  <i>Brain<\/i>, 130, 1224-1234.","DOI":"10.1093\/brain\/awm047"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Oliveira, R. &amp; Oliveira, S.(2019)  Letter to the Editor - Late-onset neuromyelitis optica associated with cryptogenic organizing pneumonia.  <i>Mult. Scler. Relat. Disord<\/i>., 36, 101398.","DOI":"10.1016\/j.msard.2019.101398"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Otake, K., Tagami, T., Kido, N., Watanabe, A., Sakamaki, M., Mochizuki, T. &amp; Matsuda, K.(2021)  Neuromyelitis optica with rapid respiratory failure: a case report.  <i>Acute Med. Surg<\/i>., 8, e655.","DOI":"10.1002\/ams2.655"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ra, S.W., Lim, S., Cha, H.J. &amp; Kim, S.(2022)  A Case of Late-Onset Neuromyelitis Optica Spectrum Disorder Associated With Cryptogenic Organizing Pneumonia.  <i>Clin. Med. Insights Case Rep<\/i>., 15, 11795476221100598.","DOI":"10.1177\/11795476221100598"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ratelade, J., Bennett, J.L. &amp; Verkman, A.S.(2011)  Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.  <i>PLoS One<\/i>, 6, e27412.","DOI":"10.1371\/journal.pone.0027412"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ruisanchez Nieva, A., Sanchez Menoyo, J.L., Escalza Cortina, I., Foncea Beti, N., Gomez Beldarrain, M. &amp; Garcia-Monco, J.C.(2017)  Neuromyelitis optica spectrum disorder in the elderly associated with bronchiolitis obliterans organizing pneumonia.  <i>Neurol. Clin. Pract<\/i>., 7, 404-406.","DOI":"10.1212\/CPJ.0000000000000336"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Shafiq, I., Wahla, A.S., Uzbeck, M.H., Khan, N. &amp; Zoumot, Z.(2022)  Neuromyelitis Optica Spectrum Disorder Associated with Cryptogenic Organizing Pneumonia in a Young Patient.  <i>Eur. J. Case Rep. Intern. Med<\/i>., 9, 003105.","DOI":"10.12890\/2022_003105"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Shang, K., Qin, C., Bu, B.T. &amp; Tian, D.S.(2019)  Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder subsequent to rhabdomyolysis: a case report and literature review.  <i>Int. J. Neurosci<\/i>., 129, 930-932.","DOI":"10.1080\/00207454.2019.1579718"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Shouman, K., Prieto, P.G., Stino, A.M. &amp; Lisak, R.P.(2019)  Serum Creatine Kinase in Patients with Neuromyelitis Optica Spectrum Disorder.  <i>J. Neuroimmunol<\/i>., 330, 87-89.","DOI":"10.1016\/j.jneuroim.2018.12.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Sun, H., Ma, X., Sun, X., Wu, L. &amp; Huang, D.(2020)  Is transient hyperCKemia a new feature of neuromyelitis optica spectrum disorders? A retrospective study in 439 patients.  <i>J. Neuroimmunol<\/i>., 343, 577228.","DOI":"10.1016\/j.jneuroim.2020.577228"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Suzuki, N., Takahashi, T., Aoki, M., Misu, T., Konohana, S., Okumura, T., Takahashi, H., Kameya, S., Yamaki, K., Kumagai, T., Fujihara, K. &amp; Itoyama, Y.(2010)  Neuromyelitis optica preceded by hyperCKemia episode.  <i>Neurology<\/i>, 74, 1543-1545.","DOI":"10.1212\/WNL.0b013e3181dd445b"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Verkman, A.S.(2012)  Aquaporins in clinical medicine.  <i>Annu. Rev. Med<\/i>., 63, 303-316.","DOI":"10.1146\/annurev-med-043010-193843"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Wingerchuk, D.M., Banwell, B., Bennett, J.L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., Jarius, S., Lana-Peixoto, M., Levy, M., Simon, J.H., Tenembaum, S.,  et al.(2015)  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.  <i>Neurology<\/i>, 85, 177-189.","DOI":"10.1212\/WNL.0000000000001729"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yokoyama, N., Niino, M., Takahashi, T., Matsushima, M. &amp; Maruo, Y.(2012)  Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report.  <i>Eur. J. Neurol<\/i>., 19, e143.","DOI":"10.1111\/j.1468-1331.2012.03880.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Zhang, W., Dong, M., Dong, H., Wang, W., Sun, W., Hao, Y., Jiao, Y., Cui, L. &amp; Jiao, J.(2020a)  Reduced sarcolemmal aquaporin 4 expression can support the differential diagnosis of neuromyelitis optica spectrum disorders.  <i>J. Neuroimmunol<\/i>., 339, 577121.","DOI":"10.1016\/j.jneuroim.2019.577121"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Chen, H., Shi, Z., Du, Q., Qiu, Y., Zhao, Z., Wang, J., Yan, C., Zhang, Q., Yang, M. &amp; Zhou, H.(2020b)  AQP4-IgG may cause muscle damage in patients with neuromyelitis optica spectrum disorder.  <i>Mult. Scler. Relat. Disord<\/i>., 42, 102126.","DOI":"10.1016\/j.msard.2020.102126"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/4\/266_2025.J007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T04:01:23Z","timestamp":1754712083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/4\/266_2025.J007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j007","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025.J007"}}